94487 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
TARGETED PROTEIN DEGRADATION
#2INHIBITORS OF MPTP
#3HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
#4INHIBITORS OF MPTP
#5ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES
#6Charge Generation Layer Comprising a Compound of Formula (I), Organic Electronic Device and Display Device Comprising the Charge Generation Layer as Well as Compounds of Formula (I)
#7CRBN LIGANDS AND USES THEREOF
#8ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#9SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#10Heteroaryl Compounds as Ligand Directed Degraders of IRAK4
#11COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY
#12DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
#13COMPOSITIONS ISOLATED FROM DATE PALM TREE
#14CRBN ligands and uses thereof
#15COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#16Prolyl Hydroxylase Inhibitors
#17CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2
#18Hydantoin containing deoxyuridine triphosphatase inhibitors
#19CARBOXYLIC ACID DERIVATIVE-SUBSTITUTED IMINO ARYL COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF
#20INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF THE SAME
#21Self healing lithium-ion battery
#22ANTIMALARIAL AGENTS
#23NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#24Hydantoin containing deoxyuridine triphosphatase inhibitors
#25TARGETED PROTEIN DEGRADATION
#26Aryl-n-aryl derivatives for treating a RNA virus infection
#27COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
#28ANTIMALARIAL AGENTS
#29ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES
#30Antibacterial activity of functionalized dihydropyrimidines
#31Compositions and methods for the treatment of fungal infections
#32Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#33CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS
#34Prolyl hydroxylase inhibitors
#35Aryl-n-aryl derivatives for treating a RNA virus infection
#36INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
#37DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
#38ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
#39Biemamides and related scaffolds as inhibitors of transforming growth factor-beta signaling
#40Antimalarial hexahydropyrimidine analogues
#41Compositions and methods for the treatment of fungal infections
#42Compositions and methods for the treatment of fungal infections
#43CRBN ligands and uses thereof
#44Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#45Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#46Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
#47Deoxyuridine triphosphatase inhibitors
#48Hydantoin containing deoxyuridine triphosphatase inhibitors
#49IMIDAZOLIDINEDIONE DERIVATIVES
#50Prolyl Hydroxylase Inhibitors
#51Biemamides and related scaffolds as inhibitors of transforming growth factor-beta signaling
#52Uracil containing compounds
#53Hydantoin containing deoxyuridine triphosphatase inhibitors
#54Compounds useful as modulators of TRPM8
#55DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
#56Amino sulfonyl compounds
#57Therapeutic compounds
#58Salts of 2,6-dimethylpyrimidone derivatives and uses thereof
#596-membered uracil isosteres
#60Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile
#61Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#62Imidazolidinedione derivatives
#63Antimicrobial Compounds And Methods Of Making And Using The Same
#64Deoxyuridine triphosphatase inhibitors
#65Prolyl hydroxylase inhibitors
#66Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#67INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
#68THERAPEUTIC COMPOUNDS
#69SecA INHIBITORS AND METHODS OF MAKING AND USING THEREOF
#70Compounds and their use as BACE1 inhibitors
#71Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
#72Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#73Hydantoin containing deoxyuridine triphosphatase inhibitors
#74Hydantoin containing deoxyuridine triphosphatase inhibitors
#75Crystal of uracil compound
#76Dithiolene metal complex colorless IR absorbers
#77Methods and compositions for treating pain
#78Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile
#79ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
#80Imidazolidinedione derivatives
#81Use of metal-accumulating plants for the preparation of catalysts that can be used in chemical reactions
#82Compounds useful as modulators of TRPM8
#83Dithiolene metal complex colorless IR absorbers
#84Imidazoyl anilide derivatives and methods of use
#85Preparation method for revaprazan hydrochloride
#86MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS
#87Imidazolidinedione derivatives
#88Dithiolene metal complex colorless IR absorbers
#89Ethynyl derivatives
#90Kinase inhibitors
#91Prolyl hydroxylase inhibitors
#92Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#93Method, device, and system for radio resource management measurement
#94Dihydropyrimidin-2-one compounds and medical use thereof
#95One-component reagent for the fluoroalkylation reaction
#96INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
#97Antimicrobial compounds and methods of making and using the same
#98Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#99USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS
#100Compounds useful as modulators of TRPM8
#101Use of metal-accumulating plants for implementing chemical reactions
#102Modulators of virus assembly as antiviral agents
#103Carbon nanomaterial having higher order structure by means of multiple hydrogen bonds and method for preparing same
#104KINASE INHIBITORS
#105DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER
#106SecA inhibitors and methods of making and using thereof
#107Heterocyclic compound
#108Heterocyclic aspartyl protease inhibitors
#109Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2
#110Pyrimidine cyclohexyl glucocorticoid receptor modulators
#1114-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
#112Imidazolidinedione derivatives
#1134,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
#114Agents that prevent or repair skin damage
#115Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof
#1161,4,5,6-TETRAHYDRO-PYRIMIDIN-2-YLAMINE COMPOUNDS
#117(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors
#118Organic electroluminescence element
#119Anti-infective agents and uses thereof
#120Pyrimidinone compounds and their use
#121Anti-infective agents and uses thereof
#122HIV replication inhibitors
#123Methods and compositions for treating pain
#124Androgen receptor antagonists and uses thereof
#125Heterocyclic aspartyl protease inhibitors
#1264-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
#127Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
#128Fluoro-homoneplanocin A and nucleoside derivatives, method for the synthesis thereof, and the pharmaceutical compositions comprising the same as an active component for treatment of cancer
#129Agent for inducing endogenous interferon
#130PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASE OR CONDITIONS MEDIATED BY LP-PLA2
#131Drug for treating liver lesions caused by the action of chemical or biological agents
#132Fluoroalkylation methods and reagents
#133Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide
#134Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists
#135Cyclic N,N′-diarylthioureas and N,N′-diarylureas-androgen receptor antagonists, anticancer agent, method for preparation and use thereof
#136Antimicrobial compounds and methods of making and using the same
#137Prolyl hydroxylase inhibitors
#138Pyrimidine cyclohexyl glucocorticoid receptor modulators
#139BICYCLO[6.1.0]NON-4-YNE REGENTS FOR CHEMICAL MODIFICATION OF OLIGONUCLEOTIDES
#140Heterocyclic aspartyl protease inhibitors
#141Use of metal-accumulating plants for implementing chemical reactions
#142Imidazolidinedione derivatives
#143Preparation of aminopyrimidine compounds
#144Heterocyclic aspartyl protease inhibitors
#145(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors
#146Phenylalanine derivatives
#147Anti-infective agents and uses thereof
#148Heterocyclic aspartyl protease inhibitors
#149Heterocyclic aspartyl protease inhibitors
#150Anti-infective agents and uses thereof
#151Pyrimidine derivatives and their use in perfume compositions
#152Wnt pathway antagonists
#153Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use
#154Anti-infective agents and uses thereof
#155Platelet ADP receptor inhibitors
#156Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
#157Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA
#158Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
#159TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
#1601,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
#161Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
#162Heterocyclic aspartyl protease inhibitors
#163PLATELET ADP RECEPTOR INHIBITORS
#164DIHYDROPYRIDIMIDINONE COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND PROCESS FOR PREPARING THE SAME
#165Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
#166Uracil derivatives and use thereof
#167Preparation of aminopyrimidine compounds
#1683,4-DIHYDROPYRIMIDINE TRPA1 ANTAGONISTS
#169Anti-infective agents and uses thereof
#170Phenylalanine derivatives
#1714-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
#172Dihydropyrimidone amides as P2X7 modulators
#173Methods and compositions for treating asthma
#174Heterocyclic aspartyl protease inhibitors
#175Dihydropyrimidinones
#176Inflammatory cytokine release inhibitor
#177Methods and compositions for treating pain
#178HIV Protease Inhibiting Compounds
#179Platelet ADP receptor inhibitors
#180NOVEL SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE
#181Heterocyclic derivatives
#182Piperazine Compounds With Herbicidal Action
#183Prolyl hydroxylase inhibitors
#184Cyclopropane compounds and pharmaceutical use thereof
#185CATIONIC LIPIDS AND USES THEREOF
#186Pyrimidylmethyl-sulfonamide compounds
#1872-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
#188I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
#189DITHIOLENE METAL COMPLEX COLORLESS IR ABSORBERS
#190USE OF1,4-DIARYL-DIHYDROPYRIMIDINE-2-ON DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTENSION
#191Heterocyclic aspartyl protease inhibitors
#192Process for the preparation of pyrimidine compounds
#193Heterocyclic aspartyl protease inhibitors
#194Novel 2-Aminopyrimidinone Derivatives And Their Use
#195INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#196Anti-infective agents and uses thereof
#197Anti-infective agents and uses thereof
#198Multimers of Heterocyclic Compounds and Their Use
#199Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors
#200Non-nucleoside reverse transcriptase inhibitors
#201Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related Pathologies
#202INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#203Cyclopropane compounds and pharmaceutical use thereof
#204Novel sulfonamide inhibitors of aspartyl protease
#205Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6H)-Yl]-N-(2-hydroxyethyl)-4-methylbenzamide
#206CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#207Sulphonamide Derivatives
#208Novel 2-Aminopyrimidinone Derivatives And Their Use
#209INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#210Heterocyclic aspartyl protease inhibitors
#211Platelet ADP receptor inhibitors
#212Novel Dihydropyrimidine Derivatives And Their Use As Anti-Cancer Agents
#213Retroviral protease inhibiting compounds
#214Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers
#2151,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
#216Preparation of aminopyrimidine compounds
#217Heterocyclic derivatives
#218Methods and compositions for treating pain
#219Imidazoyl-benzamide anti-cancer agents
#220Platelet ADP receptor inhibitors
#221PRIMIDONE PROCESS AND COMPOSITIONS
#2223,5-Difluoropyridines
#223Heterocyclic aspartyl protease inhibitors
#224Insecticidal phthalamide derivatives
#225Phenylalanine derivatives
#226Cyclopropane compounds and pharmaceutical use thereof
#227Platelet ADP receptor inhibitors
#228Sulfonamide inhibitors of aspartyl protease
#229Substituted p-diaminobenzene derivatives
#230Aminobenzophenone compounds
#231Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
#232Solid-phase fluorination of uracil and cytosine
#233Hepatitis c virus inhibitors
#2341-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
#235Heterocyclic aspartyl protease inhibitors
#236Novel compounds and their uses
#237Process for the preparation of pyrimidine compounds
#238Compounds, compositions, and methods
#2396-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
#240Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
#241Platelet ADP receptor inhibitors
#242Substituted dihydropyrimidinone preparation using polyaniline salt catalyst
#243HIV protease inhibiting compounds
#244Trp-p8 active compounds and therapeutic treatment methods
#245Substituted 1,4-dihydropyrimidines as antitubercular agents
#246Dihydropyrimidones and pharmaceutical compositions thereof
#247Method for treating cancer using a dihydropyrimidine derivative